Induction of cytochrome P4503A by the antiglucocorticoid mifepristone and a novel hypocholesterolaemic drug

Drug Metabolism and Disposition

Volumn 25, Issue 6, 1997, Pages 757-761

  Williams, J Andrew ^a,b   Chenery, Richard J ^c   Berkhout, Theo A ^c   Hawksworth, Gabrielle M ^c  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DEXAMETHASONE; HYPOCHOLESTEROLEMIC AGENT; MIFEPRISTONE; SR 12813; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DRUG METABOLISM; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; LIVER MICROSOME METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; STEROID HYDROXYLATION;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ARYL HYDROCARBON HYDROXYLASES; BLOTTING, WESTERN; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; DIPHOSPHONATES; ENZYME INDUCTION; FEMALE; HORMONE ANTAGONISTS; LIVER; MIFEPRISTONE; OXIDOREDUCTASES, N-DEMETHYLATING; RATS; RATS, SPRAGUE-DAWLEY; TESTOSTERONE;

ANIMALIA;

EID: 0030987376     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. L. M. Forrester, C. J. Henderson, M. J. Glancey, D. J. Back, B. K. Park, S. E. Ball, N. R. Kitteringham, A. W. McLaren, J. S. Miles, P. Skett, and C. R. Wolf: Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs ands xenobiotics. Biochem. J. 281, 359-368 (1992).
2. D. A. Smith: Species differences in metabolism and pharmacokinetics: are we close to an understanding? Drug Metab. Rev. 23, 355-373 (1991).
3. G. J. Buckart, R. Venkataramanan, T. E. Starzl, R. J. Ptachkinski, J. C. Gartner et al.,: Cyclosporine clearance in children following organ transplantation. J. Clin. Pharmacol. 24, 412 (1984).
4. F. P. Guengerich. Minireview: Metabolism of 17α-ethinyl estradiol in humans. Life Sci. 47, 1981-1988 (1990).
5. G. Klintmalm, J. Sawe, O. Ringden, C. von Bahr, and A. Magnusson: Cyclosporine plasma levels in renal transplant patients. Transplantation 39, 132-137 (1985).
6. D. L. Modry, E. B. Stinson, P. E. Oyer, S. W. Jamieson, J. C. Baldwin, and N. E. Shumway: Acute infection and massive cyclosporine requirements in heart transplant recipients treated with rifampicin. Transplantation 39, 313-314 (1985).
7. P. S. Guzelian: Regulation of the glucocorticoid-inducible cytochromes P450. In "Microsomes and Drug Oxidations" pp. 148-155. (J. O. Miners, D. J. Birkett, R. Drew, and M. McManus, eds.) Taylor and Francis, London, 1988.
8. U. Karayalcin, Y. Takeda, I. Miyamori, T. Morise, and R. Takeda: Effect of the 3-hydroxy-3-methylglutarate coenzyme A inhibitor pravastatin on urinary 6β-hydroxycortisol excretion: a preliminary study. Steroids 56, 598-600 (1991).
9. T. A. Kocarek, E. G. Schuetz, P. S. Guzelian: Regulation of cytochrome P4502B1/2 mRNA expression by lovastatin and oxysterols in primary cultures of adult rat hepatocytes. Toxicol. Appl. Pharmacol. 120, 298-307 (1993).
10. A. J. Sonderfan, M. P. Arlotto, D. Dutton, S. K. McMillen, and A. Parkinson: Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P450. Arch. Biochem. Biophys. 255, 27-41 (1987).
11. K. Oguri, H. Yamada, and H. Yoshimura: Regiochemistry of cytochrome P450 (testosterone). Annu. Rev. Pharmacol. Toxicol. 34, 251-279 (1994).
12. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall: Protein measurement with the Polin phenol reagent. J. Biol. Chem. 193, 265-275 (1951).
13. Y. Funae and S. Imoaka: Purification and characterisation of liver microsomal cytochrome P450 from untreated rats. Biochim. Biophys. Acta. 926, 349-358 (1987).
14. S. Ekins, G. I. Murray, M. D. Burke, J. A. Williams, N. C. Marchant, and G. M. Hawksworth: Quantitative differences in Phase I and II metabolism between precision-cut liver slices and isolated hepatocytes. Drug Metab. Dispos. 23, 1274-1279 (1995).
15. U. K. Laemmli: Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature (Lond.) 227, 680-685 (1970).
16. H. Towbin, T. Staehelin, and J. Gordon: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: procedure and some applications. Proc. Nat. Acad. Sci. 76, 4350-4354 (1979).
17. E. G. Schuetz and P. S. Guzelian: Induction of cytochrome P450 by glucocorticoids in rat liver: II. Evidence that glucocorticoids regulate induction of cytochrome P450 by a non-classical receptor mechanism. J. Biol. Chem. 259, 2007-2012 (1984).
18. D. Gagne, M. Pons, and D. Philibert. RU 38486: A potent antigluocorticoid in vitro and in vivo. J. Steroid. Biochem. 23, 247-251 (1985).
19. H. J. Burger, J. D. Schuetz, E. G. Schuetz, and P. S. Guzelian: Paradoxical transcriptional activation of rat liver cytochrome P450 3A1by dexamethasone and the anti-glucocorticoid pregnenolone 16α-carbonitrile: analysis by transient transfection into primary monolayer cultures of adult rat hepatocytes. Proc. Nat. Acad. Sci. 89, 2145-2149 (1992).
20. E. G. Schuetz, J. D. Schuetz, S. C. Strom, M. T. Thompson, R. A. Fisher, D. T. Molowa, D. Li, P. S. Guzelian: Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology, 18, 1254-62 (1993).
21. T. A. Kocarek, E. G. Schuetz, S. C. Strom, R. A. Fisher, and P. S. Guzelian: Comparative analysis of cytochrome P4503A induction in cultures of rat, rabbit and human hepatocytes. Drug Metab. Dispos. 23, 415-421 (1995).
22. E. G. Schuetz, G. A. Hazleton, J. Hall, P. B. Watkins, C. D. Klaasen, and P. S. Guzelian: Induction of digitoxigenin monodigitoxoside UDP-glucuronyltransferase activity by glucocorticoids and other inducers of cytochrome P450p in primary monolayer cultures of adult rat hepatocytes and in human liver. J. Biol. Chem. 261, 8270-8275 (1986).
23. T. A. Kocarek, E. G. Schuetz, and P. S. Guzelian: Differential induction of cytochrome P450b/e and P450p mRNAs by dose of phenobarbital in primary cultures of adult rat hepatocytes. Mol. Pharmacol. 38, 440-444 (1990).
24. P. M. Shaw, M. Adesnik, M. C. Weiss, and L. Corcos: The phenobarbital-induced transcriptional activation of cytochrome P450 genes is blocked by the glucocorticoid-progesterone antagonist RU486. Mol. Pharmacol. 44, 775-783 (1993).
25. Y. Horsmans, J. P. Desager, V. Van Den Berghe, M. Abrassart, and C. Harvengt: Effects of simvastatin and pravastatin on 6β-hydroxycortisol excretion, a potential marker of cytochrome P4503A. Pharmacol. Res. 28, 243-248 (1993).
26. T. A. Berkhout, H. M. Simon, D. R. Patel, C. Bentzen, E. Niesor, B. Jackson, and K. E. Suckling: The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutary]-coenzyme A Reductase. J. Biol. Chem. 271, 14376-14382 (1996).
27. J. L. Goldstein and M. S. Brown: Regulation of the mevalonate pathway. Nature (Lond.) 343, 425-430 (1990).
28. M. Stromstedt, D. Rozman, and M. R. Waterman: The ubiquitously expressed human CYP51 encodes 14-alpha-demethylase, a cytochrome P450 whose expression is regulated by oxysterols. Arch. Biochem. Biophys. 329, 73-81 (1996).
29. A. W. Alberts, J. Chen, G. Kuron, V. Hunt, J. Huff, C. Hoffman, J. Rothrock, M. Lopez. H. Joshua, E. Harris, A. Patchett, R. Monaghan, S. Currie, E. Stapley, G. Alberschonberg, O. Hensens, J. Hirshfield, K. Hoogsteen, J. Liesch, and J. Springer: Mevinolin: A highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc. Nat. Acad. Sci. 77, 3957-3961 (1980).